Gefitinib and Erlotinib Lead to Phosphorylation of Eukaryotic Initiation Factor 2 Alpha Independent of Epidermal Growth Factor Receptor in A549 Cells

Gefitinib and erlotinib are anticancer agents, which inhibit epidermal growth factor receptor (EGFR) tyrosine kinase. Interstitial lung disease (ILD) occurs in patients with non-small cell lung cancer receiving EGFR inhibitors. In the present study, we examined whether gefitinib- and erlotinib-induc...

Descripción completa

Detalles Bibliográficos
Autores principales: Koyama, Satoshi, Omura, Tomohiro, Yonezawa, Atsushi, Imai, Satoshi, Nakagawa, Shunsaku, Nakagawa, Takayuki, Yano, Ikuko, Matsubara, Kazuo
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2015
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4545731/
https://www.ncbi.nlm.nih.gov/pubmed/26288223
http://dx.doi.org/10.1371/journal.pone.0136176

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4545731/
https://www.ncbi.nlm.nih.gov/pubmed/26288223
http://dx.doi.org/10.1371/journal.pone.0136176

Ejemplares similares